Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Cardiol

Retrieve available abstracts of 76 articles:
HTML format

Single Articles

    March 2023
  1. CHOW JK, Bagai A, Tan MK, Har BJ, et al
    Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.
    J Cardiol. 2023 Mar 15:S0914-5087(23)00052-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available

  2. BUKHARI S, Khan B
    Prevalence of Ventricular Arrhythmias and Role of Implantable Cardioverter-Defibrillator in Cardiac Amyloidosis.
    J Cardiol. 2023 Mar 7:S0914-5087(23)00048-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available

  3. TERASAKA N, Spanopoulos D, Miyagoshi H, Kubo T, et al
    Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
    J Cardiol. 2023;81:316-322.
    PubMed     Abstract available

    February 2023
  4. MIYAZAKI Y, Yamagata K, Wakamiya A, Shimamoto K, et al
    Adding interactive face-to-face lectures to passive lectures effectively reduces radiation exposure during atrial fibrillation ablation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00044-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available

  5. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00043-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available

  6. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available

  7. KATAOKA N, Imamura T, Uchida K, Koi T, et al
    Urgent catheter ablation in Japanese patients with mechanical circulatory supports suffering from refractory ventricular electrical storm.
    J Cardiol. 2023;81:229-235.
    PubMed     Abstract available

    January 2023
  8. WADA H, Miyauchi K, Suwa S, Miyazaki S, et al
    Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.
    J Cardiol. 2023 Jan 12:S0914-5087(22)00331-8. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available

    Catheter ablation of ventricular tachycardia associated with structural heart disease: Current status and perspectives.
    J Cardiol. 2023;81:57-62.
    PubMed     Abstract available

    December 2022
  10. GASSANOV N, Mutallimov M, Caglayan E, Erdmann E, et al
    ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    J Cardiol. 2022;80:573-577.
    PubMed     Abstract available

    November 2022
  11. IKEDA T, Yamashita T, Akao M, Atarashi H, et al
    Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    J Cardiol. 2022 Nov 22:S0914-5087(22)00282-9. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available

  12. UENO H, Imamura T, Tanaka S, Fukuda N, et al
    Left atrial appendage closure for stroke prevention in nonvalvular atrial fibrillation: A current overview.
    J Cardiol. 2022 Nov 15. pii: S0914-5087(22)00277.
    PubMed     Abstract available

  13. CHEN WT, Li CH, Chou YH, Lin WL, et al
    Post-ablation augmentation of skin sympathetic nerve activity predicts a poor outcome of idiopathic ventricular arrhythmias.
    J Cardiol. 2022 Nov 10. pii: S0914-5087(22)00274.
    PubMed     Abstract available

    October 2022
  14. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    PubMed     Abstract available

  15. DING L, Weng S, Zhang H, Yu F, et al
    Novel tissue-pressure sensing technology using a wide-band dielectric imaging system: An in vivo study.
    J Cardiol. 2022;80:319-324.
    PubMed     Abstract available

  16. NIEHUES P, Wegner FK, Wolfes J, Willy K, et al
    Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS.
    J Cardiol. 2022;80:298-302.
    PubMed     Abstract available

    September 2022
  17. PATSIOU V, Samaras A, Kartas A, Moysidis DV, et al
    Prognostic implications of adherence to OACs among patients with atrial fibrillation: Insights from MISOAC-AF trial.
    J Cardiol. 2022 Sep 27. pii: S0914-5087(22)00241.
    PubMed     Abstract available

  18. HATORI Y, Sakai H, Hatori N, Kunishima T, et al
    Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
    J Cardiol. 2022 Sep 12. pii: S0914-5087(22)00220.
    PubMed     Abstract available

    August 2022
  19. MATSUDA S, Kato T, Morimoto T, Taniguchi T, et al
    Atrial fibrillation in patients with severe aortic stenosis.
    J Cardiol. 2022 Aug 23. pii: S0914-5087(22)00206.
    PubMed     Abstract available

  20. AKAO M, Tsuji H, Kusano K, Matsui K, et al
    Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study.
    J Cardiol. 2022 Aug 16. pii: S0914-5087(22)00200.
    PubMed     Abstract available

  21. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available

    July 2022
  22. YAMAZAKI K, Ishida Y, Sasaki S, Toyama Y, et al
    Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    J Cardiol. 2022 Jul 25. pii: S0914-5087(22)00160.
    PubMed     Abstract available

    June 2022
  23. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Corrigendum to 'Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry' [Journal of Cardiology 72 (2018) 300-306].
    J Cardiol. 2022 Jun 29. pii: S0914-5087(22)00154.

  24. HEMMI H, Kataoka N, Imamura T
    Paroxysmal atrial fibrillation as a cause of unexplained syncope.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00139.

  25. YAMASHITA T, Uchiyama S, Atarashi H, Okumura K, et al
    Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2.
    J Cardiol. 2022 Jun 15. pii: S0914-5087(22)00096.
    PubMed     Abstract available

  26. FUKUNAGA M, Isotani A, Shirai S, Murakami N, et al
    Initial practice of left atrial appendage closure device in Japan; single-center experience.
    J Cardiol. 2022;79:752-758.
    PubMed     Abstract available

    April 2022
  27. VARNEY JA, Dong VS, Tsao T, Sabir MS, et al
    COVID-19 and arrhythmia: An overview.
    J Cardiol. 2022;79:468-475.
    PubMed     Abstract available

  28. KUNO T, Takahashi M, So M, Egorova NN, et al
    The association of anticoagulation before admission and survival of patients with COVID-19.
    J Cardiol. 2022;79:489-493.
    PubMed     Abstract available

    March 2022
  29. MIYAZAKI S, Miyauchi K, Hayashi H, Yamashiro K, et al
    Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    J Cardiol. 2022 Mar 25. pii: S0914-5087(22)00058.
    PubMed     Abstract available

  30. CHEN WT, Lo LW, Tsai WC, Lin YJ, et al
    Application of dynamic display technology to identify gaps after pulmonary vein isolation in catheter ablation of atrial fibrillation.
    J Cardiol. 2022 Mar 23. pii: S0914-5087(22)00052.
    PubMed     Abstract available

  31. MIYAZAKI Y, Yamagata K, Ishibashi K, Inoue Y, et al
    Paroxysmal atrial fibrillation as a predictor of pacemaker implantation in patients with unexplained syncope.
    J Cardiol. 2022 Mar 12. pii: S0914-5087(22)00049.
    PubMed     Abstract available

  32. OGURA S, Nakamura K, Morita H, Nakagawa K, et al
    Fragmented QRS as a predictor of cardiac events in patients with cardiac sarcoidosis.
    J Cardiol. 2022;79:446-452.
    PubMed     Abstract available

    February 2022
  33. YAMANE T
    Catheter ablation of atrial fibrillation: Current status and near future.
    J Cardiol. 2022 Feb 24. pii: S0914-5087(22)00025.
    PubMed     Abstract available

  34. MORI H, Fukui K, Maeda A, Akashi Y, et al
    Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00029.
    PubMed     Abstract available

  35. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available

  36. OUCHI K, Sakuma T, Higuchi T, Yoshida J, et al
    Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
    J Cardiol. 2022;79:211-218.
    PubMed     Abstract available

    Effectiveness and safety of transcatheter left atrial appendage closure.
    J Cardiol. 2022;79:186-193.
    PubMed     Abstract available

    January 2022
  38. CHEN JY, Chen TW, Lu WD
    The HAT2CH2 score predicts neurologic events in patients with cardiac implantable electronic devices without atrial fibrillation.
    J Cardiol. 2022 Jan 8. pii: S0914-5087(21)00385.
    PubMed     Abstract available

  39. MIYAZAKI A, Uemura H
    Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch.
    J Cardiol. 2022;79:30-35.
    PubMed     Abstract available

    December 2021
  40. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    PubMed     Abstract available

  41. KURAOKA A, Ishizu T, Sato M, Igarashi M, et al
    Left atrial regional strain assessed by novel dedicated three-dimensional speckle tracking echocardiography.
    J Cardiol. 2021;78:517-523.
    PubMed     Abstract available

    November 2021
  42. VALLES E, Marti-Almor J, Grau N, Casteigt B, et al
    Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00288.
    PubMed     Abstract available

  43. WANG Y, Shao C, Qi L, Tan J, et al
    EphrinB2-RhoA upregulation attenuates sympathetic hyperinnervation and decreases the incidence of ventricular arrhythmia after myocardial infarction.
    J Cardiol. 2021 Nov 5. pii: S0914-5087(21)00290.
    PubMed     Abstract available

  44. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    PubMed     Abstract available

  45. LAO N, Lim J, Bashir H, Mahalwar G, et al
    Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.
    J Cardiol. 2021 Nov 1. pii: S0914-5087(21)00305.
    PubMed     Abstract available

    October 2021
  46. NAGANO T, Yasuoka R, Tanaka M, Maruyama M, et al
    A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 29. pii: S0914-5087(21)00244.
    PubMed     Abstract available

  47. OBAYASHI Y, Miyake M, Amano M, Kitai T, et al
    Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 26. pii: S0914-5087(21)00273.
    PubMed     Abstract available

  48. TU T, Li B, Li X, Zhang B, et al
    Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation.
    J Cardiol. 2021 Oct 23. pii: S0914-5087(21)00207.
    PubMed     Abstract available

  49. WEI F, Ren W, Zhang X, Wu P, et al
    miR-425-5p is negatively associated with atrial fibrosis and promotes atrial remodeling by targeting CREB1 in atrial fibrillation.
    J Cardiol. 2021 Oct 20. pii: S0914-5087(21)00253.
    PubMed     Abstract available

  50. FUKUSHIMA S, Suzuki K, Kawamoto N, Kakuta T, et al
    Launching minimally invasive stand-alone maze procedure for atrial fibrillation.
    J Cardiol. 2021 Oct 5. pii: S0914-5087(21)00256.
    PubMed     Abstract available

  51. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.

    September 2021
  52. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available

  53. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed     Abstract available

    August 2021
  54. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available

  55. UKITA K, Egami Y, Kawamura A, Nakamura H, et al
    Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00199.
    PubMed     Abstract available

    July 2021
  56. TOHOKU S, Bordignon S, Chen S, Bologna F, et al
    Validation of lesion durability following pulmonary vein isolation using the new third-generation laser balloon catheter in patients with recurrent atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00167.
    PubMed     Abstract available

  57. LAI SW
    Urine dipstick proteinuria and atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00179.

  58. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    PubMed     Abstract available

    June 2021
  59. RAMESH T, Lee PYK, Mitta M, Allencherril J, et al
    Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2021 Jun 20. pii: S0914-5087(21)00151.
    PubMed     Abstract available

  60. TAKAHIRA H, Kajiyama T, Kondo Y, Nakano M, et al
    Pathophysiological background and prognosis of common atrial flutter in non-elderly patients: Comparison to Atrial Fibrillation.
    J Cardiol. 2021 Jun 14. pii: S0914-5087(21)00132.
    PubMed     Abstract available

    Cardiac reverse remodeling following catheter ablation of atrial fibrillation.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00134.

  62. KUSUNOSE K, Takahashi H, Nishio S, Hirata Y, et al
    Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.
    J Cardiol. 2021 Jun 9. pii: S0914-5087(21)00129.
    PubMed     Abstract available

  63. IWANO T, Toda H, Nakamura K, Shimizu K, et al
    Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00113.
    PubMed     Abstract available

  64. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available

  65. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    PubMed     Abstract available

    May 2021
  66. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available

    April 2021
  67. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available

  68. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    PubMed     Abstract available

  69. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed     Abstract available

  70. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    PubMed     Abstract available

    March 2021
  71. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    PubMed     Abstract available

    February 2021
  72. WILLY K, Dechering DG, Reinke F, Bogeholz N, et al
    The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications.
    J Cardiol. 2021;77:154-159.
    PubMed     Abstract available

  73. KISHIMA H, Mine T, Fukuhara E, Ishihara M, et al
    Left ventricular stiffness assessed by diastolic Wall strain predicts asymptomatic atrial high-rate episodes in patients with pacemaker implantation.
    J Cardiol. 2021;77:195-200.
    PubMed     Abstract available

  74. CHEN JY, Lu WD
    Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers.
    J Cardiol. 2021;77:166-173.
    PubMed     Abstract available

    August 2020
  75. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    PubMed     Abstract available

    May 2020
  76. WILLY K, Reinke F, Bogeholz N, Ellermann C, et al
    The role of entirely subcutaneous ICD systems in patients with dilated cardiomyopathy.
    J Cardiol. 2020;75:567-570.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.